| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | carbohydrate binding | 3.52e-05 | 310 | 104 | 9 | GO:0030246 | |
| Domain | Med12 | 2.95e-05 | 2 | 102 | 2 | PF09497 | |
| Domain | Mediator_Med12_catenin-bd | 2.95e-05 | 2 | 102 | 2 | IPR021989 | |
| Domain | Med12-PQL | 2.95e-05 | 2 | 102 | 2 | PF12144 | |
| Domain | Med12-LCEWAV | 2.95e-05 | 2 | 102 | 2 | PF12145 | |
| Domain | Med12 | 2.95e-05 | 2 | 102 | 2 | SM01281 | |
| Domain | Mediator_Med12 | 2.95e-05 | 2 | 102 | 2 | IPR019035 | |
| Domain | Mediator_Med12_LCEWAV | 2.95e-05 | 2 | 102 | 2 | IPR021990 | |
| Domain | SRCR | 1.96e-04 | 21 | 102 | 3 | PF00530 | |
| Domain | ConA-like_dom | 1.99e-04 | 219 | 102 | 7 | IPR013320 | |
| Domain | Anaphylatoxin_comp_syst | 2.92e-04 | 5 | 102 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 2.92e-04 | 5 | 102 | 2 | IPR001840 | |
| Domain | - | 3.33e-04 | 25 | 102 | 3 | 3.10.250.10 | |
| Domain | SR | 3.33e-04 | 25 | 102 | 3 | SM00202 | |
| Domain | SRCR-like_dom | 3.75e-04 | 26 | 102 | 3 | IPR017448 | |
| Domain | SRCR_1 | 3.75e-04 | 26 | 102 | 3 | PS00420 | |
| Domain | SRCR_2 | 3.75e-04 | 26 | 102 | 3 | PS50287 | |
| Domain | SRCR | 4.21e-04 | 27 | 102 | 3 | IPR001190 | |
| Domain | ANATO | 6.09e-04 | 7 | 102 | 2 | SM00104 | |
| Domain | DUF3585 | 6.09e-04 | 7 | 102 | 2 | IPR022735 | |
| Domain | ANAPHYLATOXIN_2 | 6.09e-04 | 7 | 102 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 6.09e-04 | 7 | 102 | 2 | PS01177 | |
| Domain | DUF3585 | 6.09e-04 | 7 | 102 | 2 | PF12130 | |
| Domain | ANATO | 6.09e-04 | 7 | 102 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 6.09e-04 | 7 | 102 | 2 | IPR000020 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 8.09e-04 | 8 | 102 | 2 | IPR019565 | |
| Domain | Thiol-ester_cl | 8.09e-04 | 8 | 102 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 8.09e-04 | 8 | 102 | 2 | IPR019742 | |
| Domain | A2M | 1.29e-03 | 10 | 102 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.29e-03 | 10 | 102 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.29e-03 | 10 | 102 | 2 | IPR011626 | |
| Domain | A2M_recep | 1.29e-03 | 10 | 102 | 2 | PF07677 | |
| Domain | A2M_comp | 1.29e-03 | 10 | 102 | 2 | PF07678 | |
| Domain | A2M_N | 1.29e-03 | 10 | 102 | 2 | PF01835 | |
| Domain | A2M_N | 1.29e-03 | 10 | 102 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.29e-03 | 10 | 102 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.29e-03 | 10 | 102 | 2 | PS00477 | |
| Domain | A2M_N_2 | 1.29e-03 | 10 | 102 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 1.29e-03 | 10 | 102 | 2 | IPR001599 | |
| Domain | PLAC | 2.57e-03 | 14 | 102 | 2 | PF08686 | |
| Domain | C345C | 3.81e-03 | 17 | 102 | 2 | SM00643 | |
| Domain | ig | 3.88e-03 | 190 | 102 | 5 | PF00047 | |
| Domain | Immunoglobulin | 3.88e-03 | 190 | 102 | 5 | IPR013151 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 4.27e-03 | 18 | 102 | 2 | IPR008930 | |
| Domain | NTR | 4.75e-03 | 19 | 102 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 4.75e-03 | 19 | 102 | 2 | IPR018933 | |
| Domain | PLAC | 4.75e-03 | 19 | 102 | 2 | PS50900 | |
| Domain | PLAC | 4.75e-03 | 19 | 102 | 2 | IPR010909 | |
| Domain | TSP_1 | 4.95e-03 | 63 | 102 | 3 | PF00090 | |
| Domain | UBA-like | 5.18e-03 | 64 | 102 | 3 | IPR009060 | |
| Domain | TSP1 | 5.41e-03 | 65 | 102 | 3 | SM00209 | |
| Domain | TSP1_rpt | 5.41e-03 | 65 | 102 | 3 | IPR000884 | |
| Domain | TSP1 | 5.41e-03 | 65 | 102 | 3 | PS50092 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 5.01e-05 | 13 | 81 | 3 | M4732 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 7.91e-05 | 15 | 81 | 3 | M7146 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 1.17e-04 | 17 | 81 | 3 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 1.94e-04 | 20 | 81 | 3 | M917 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 2.60e-04 | 22 | 81 | 3 | M39502 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 3.28e-04 | 381 | 81 | 9 | M48063 | |
| Pubmed | Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. | 5.72e-06 | 39 | 104 | 4 | 19010793 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 8.86e-06 | 2 | 104 | 2 | 16565498 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 15998580 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 8.86e-06 | 2 | 104 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 8.86e-06 | 2 | 104 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 8.86e-06 | 2 | 104 | 2 | 17645767 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 12207352 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 33354779 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 8.86e-06 | 2 | 104 | 2 | 27758680 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 8.86e-06 | 2 | 104 | 2 | 23749435 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 8.86e-06 | 2 | 104 | 2 | 3037333 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 11726230 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 8.86e-06 | 2 | 104 | 2 | 6950384 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 8.86e-06 | 2 | 104 | 2 | 8428773 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 31405565 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 8.86e-06 | 2 | 104 | 2 | 21345967 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 2572548 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 2302180 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 8.86e-06 | 2 | 104 | 2 | 18091514 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 29080553 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 8.86e-06 | 2 | 104 | 2 | 25339671 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 17728371 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6149580 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6149581 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 12115608 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 3542363 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 2387317 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 16908004 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 7365238 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 7391573 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 8.86e-06 | 2 | 104 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 8.86e-06 | 2 | 104 | 2 | 17971229 | |
| Pubmed | Epistasis between IGF2R and ADAMTS19 polymorphisms associates with premature ovarian failure. | 8.86e-06 | 2 | 104 | 2 | 24014609 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6881182 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 8.86e-06 | 2 | 104 | 2 | 17921792 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 8.86e-06 | 2 | 104 | 2 | 6978711 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 35898513 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 28873507 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 8.86e-06 | 2 | 104 | 2 | 6832377 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 3794341 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 31681284 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22785613 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 8.86e-06 | 2 | 104 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 8.86e-06 | 2 | 104 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 8.86e-06 | 2 | 104 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 8.86e-06 | 2 | 104 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 8.86e-06 | 2 | 104 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 8.86e-06 | 2 | 104 | 2 | 16098595 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 8.86e-06 | 2 | 104 | 2 | 15787745 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 30026462 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6559257 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 8.86e-06 | 2 | 104 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 8.86e-06 | 2 | 104 | 2 | 20506482 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 12480675 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 26800705 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 8.86e-06 | 2 | 104 | 2 | 15390104 | |
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 8.86e-06 | 2 | 104 | 2 | 1699796 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 8.86e-06 | 2 | 104 | 2 | 2997024 | |
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 8.86e-06 | 2 | 104 | 2 | 3624865 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 21857912 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 8.86e-06 | 2 | 104 | 2 | 4514997 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 8.86e-06 | 2 | 104 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 8.86e-06 | 2 | 104 | 2 | 3167981 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 7545960 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 30041577 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 8.86e-06 | 2 | 104 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 8.86e-06 | 2 | 104 | 2 | 34358307 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 8.86e-06 | 2 | 104 | 2 | 18360261 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 31727867 | ||
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 8.86e-06 | 2 | 104 | 2 | 26814963 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 8132550 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 2395880 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 26814708 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6192448 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6167582 | ||
| Pubmed | Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. | 8.86e-06 | 2 | 104 | 2 | 1438267 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 19150565 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 17506029 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 23715124 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 3464002 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 2993295 | ||
| Pubmed | Identification of the site of sulfation of the fourth component of human complement. | 8.86e-06 | 2 | 104 | 2 | 3944109 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 33353966 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 3008092 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 6609966 | ||
| Pubmed | Heterogeneity and linkage of equine C4 and steroid 21-hydroxylase genes. | 8.86e-06 | 2 | 104 | 2 | 2900855 | |
| Cytoband | 17q25 | 9.73e-05 | 39 | 104 | 3 | 17q25 | |
| GeneFamily | Complement system|Sushi domain containing | 4.26e-04 | 36 | 74 | 3 | 492 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 5.84e-04 | 9 | 74 | 2 | 1234 | |
| GeneFamily | Immunoglobulin like domain containing | 1.17e-03 | 193 | 74 | 5 | 594 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-07 | 180 | 104 | 7 | 5e78b29fa1cbdcf502fee3577e5b45766b90d1dc | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.38e-06 | 91 | 104 | 5 | 3f56358ff0dacdf6b8fc22cea64082231bceb851 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.29e-06 | 173 | 104 | 6 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-06 | 176 | 104 | 6 | 212e643c50c68462d4b016428ab30eeb7868ef40 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-06 | 176 | 104 | 6 | c7be4eaa5eb76ad9389fb9d15ad0934e88d267d1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-06 | 178 | 104 | 6 | ccea3c8908d72f5fecd151a133048c8e9758304c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.55e-06 | 183 | 104 | 6 | 1645d4a55cd8c22d6eb47fc5c6b1e576c454f111 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.69e-06 | 184 | 104 | 6 | 34e316ad8e7b8667cd8ad61397281802a252744f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.31e-06 | 188 | 104 | 6 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | CV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 5.99e-06 | 192 | 104 | 6 | 2a2052b44e8f679ef484f03ba4fb37b0ec841b88 | |
| ToppCell | 11.5-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 6.17e-06 | 193 | 104 | 6 | d4779d92a4dd4b8b656383e6f4fce76d3bd70931 | |
| ToppCell | 18-Distal-Mesenchymal-Cartilage|Distal / Age, Tissue, Lineage and Cell class | 6.17e-06 | 193 | 104 | 6 | 52f3d1bb8d8ca91ba12439d46392f377928ff8f8 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_Myelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.35e-06 | 199 | 104 | 6 | 2b567b6fd8addf059bbf2b72c55a7647aefdc595 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3---L2-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.56e-06 | 200 | 104 | 6 | 9c89e91bb630cc306a820927a36ea6fb3d13e9d7 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.56e-06 | 200 | 104 | 6 | 8821574d17b55dfea3ca0204e6b4c0ca6b19588a | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.56e-06 | 200 | 104 | 6 | 0f23e72649a274043bf23e0952a9b5707c516acf | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.56e-06 | 200 | 104 | 6 | 96b1d2e70fbbba744fd4356a70efcf356aca9abc | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.56e-06 | 200 | 104 | 6 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.56e-06 | 200 | 104 | 6 | ad6f1d4d7f5d7bab2ba2e4fff58c535290065c0e | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-3|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 1.70e-05 | 136 | 104 | 5 | 4f5e0b6c7d6e3e922af4daa7c3eb56490455c1df | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 138 | 104 | 5 | c1a46fbf1beffa12c3d1b78361e0613e2e9e2d13 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 142 | 104 | 5 | 67d4ff3483ae34f77c3325aa0fbd3462ca19ade4 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 148 | 104 | 5 | 7c7c87b57aa16f8b91698489df39ace5a3a53df8 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 150 | 104 | 5 | afd651c654e715414eff64cf3a37378d057a56a2 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.48e-05 | 158 | 104 | 5 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l32|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.54e-05 | 79 | 104 | 4 | 11e92ae55dae24b6f73dd5a52e1c3c4e579ddf7b | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-05 | 161 | 104 | 5 | 3a5f2877e3b29463a3a6da05009b0ab8747b4c47 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.80e-05 | 169 | 104 | 5 | 319cba07263bf41fcbcbfecd117f91b729394241 | |
| ToppCell | Club-club-3|World / Class top | 5.22e-05 | 172 | 104 | 5 | 34fbb82a2ec77dd183cf26b38edeb7e936b707bc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.36e-05 | 173 | 104 | 5 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-B_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 173 | 104 | 5 | a693772987f1baee533dd0bd285a3c7b5619a73b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.51e-05 | 174 | 104 | 5 | 9cc7251661ea2b1565eef1dfb8cf6dec3ade13d4 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-05 | 174 | 104 | 5 | 16204ff504b7b382b4d90ca35003ad5336020e07 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.66e-05 | 175 | 104 | 5 | af9c5104c86231cfdb93a0f7d7032379efaa009e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.66e-05 | 175 | 104 | 5 | 4bfae78ac3a2cb9404382aae96d291504a9cfa14 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.98e-05 | 177 | 104 | 5 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.98e-05 | 177 | 104 | 5 | 8b003ed7887479c3a010ef37dd981b748256bda7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 178 | 104 | 5 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.14e-05 | 178 | 104 | 5 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 178 | 104 | 5 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.47e-05 | 180 | 104 | 5 | e9785ac2806103f725f5a5208495826354ec6e22 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 6.64e-05 | 181 | 104 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.82e-05 | 182 | 104 | 5 | ed487f3a774812caa2903a646b60c86edcc1e65e | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 7.00e-05 | 183 | 104 | 5 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 7.18e-05 | 184 | 104 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.18e-05 | 184 | 104 | 5 | e04cabff33a8e36967622ec3e5b37b89afa7e148 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.37e-05 | 185 | 104 | 5 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 7.37e-05 | 185 | 104 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.37e-05 | 185 | 104 | 5 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.56e-05 | 186 | 104 | 5 | 153c8b2fd8a6e2141ca97c626f82e5f081f3180a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-05 | 187 | 104 | 5 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.95e-05 | 188 | 104 | 5 | 5eb107122064f0a99dfd445cc87d3766f7257216 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.95e-05 | 188 | 104 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-05 | 188 | 104 | 5 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 7.95e-05 | 188 | 104 | 5 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 189 | 104 | 5 | a618a1ddf5097a010c6c2c7341f3a0bd46a29c02 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.15e-05 | 189 | 104 | 5 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 189 | 104 | 5 | 4e61f9cd1c06bddb47ebf98affc0f97770e26e8c | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 8.15e-05 | 189 | 104 | 5 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | droplet-Heart-nan-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 189 | 104 | 5 | 0493f7b79127c207fd7ade778ef4810500495d7e | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.35e-05 | 190 | 104 | 5 | d072bb285bd34d518b958e7c9ad44739c60b359c | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 8.35e-05 | 190 | 104 | 5 | 2592765016f291565697265800a232b2edef3792 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.35e-05 | 190 | 104 | 5 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.56e-05 | 191 | 104 | 5 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.56e-05 | 191 | 104 | 5 | f9a46956778a8773d6656340ecf5d218376d79c2 | |
| ToppCell | COVID-19-Myeloid-TRAM2|Myeloid / Condition, Lineage and Cell class | 9.21e-05 | 194 | 104 | 5 | 4060a60c0271e7397b07993a1ef47b3291bba6e3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-05 | 195 | 104 | 5 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | 15-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 9.44e-05 | 195 | 104 | 5 | 414f60bc0f0d0ecb5137bcd617fae91f0c15038a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 195 | 104 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.44e-05 | 195 | 104 | 5 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 9.67e-05 | 196 | 104 | 5 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.67e-05 | 196 | 104 | 5 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.90e-05 | 197 | 104 | 5 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 9.90e-05 | 197 | 104 | 5 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | distal-Hematologic-Platelet/Megakaryocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.90e-05 | 197 | 104 | 5 | 751ffb8792058384079ebfe94872b3525f1aea84 | |
| ToppCell | distal-Hematologic-Platelet/Megakaryocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.90e-05 | 197 | 104 | 5 | e28b1b154d9588dce07c123b36f7f01fa90a5fc1 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 197 | 104 | 5 | 8786125b669d5d0b15e12df0ade6b319f09f7333 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 198 | 104 | 5 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Mesothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.01e-04 | 198 | 104 | 5 | 86736f01e61bf4961f060b24ee1f1f48340737dd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 198 | 104 | 5 | 731a90f7e68b19e387499d63e3979af78b503b0c | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-04 | 198 | 104 | 5 | 3575620db5aeaeb0bdcd7a8ff65c43abd3fa13e4 | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 1.01e-04 | 198 | 104 | 5 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | 18-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 1.04e-04 | 199 | 104 | 5 | f5d0aa4170367c080d3c2f01d9af3529762917fa | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-FILIP1L|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.06e-04 | 200 | 104 | 5 | f6af5ef02625aaae21e885e1ebd195e34731e53a | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-FILIP1L-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.06e-04 | 200 | 104 | 5 | 53f61e28c3ad6399f63c54e06120ecb5ebbf90d9 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-FILIP1L--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.06e-04 | 200 | 104 | 5 | c1f243ae929f7791e040437470033abf749b44cc | |
| ToppCell | distal-3-Hematologic-Platelet/Megakaryocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-04 | 200 | 104 | 5 | f5f5a8b0e4d802d95dc42646dd5e7d7daaad72b4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 200 | 104 | 5 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 200 | 104 | 5 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | Severe-Myeloid-Macrophages-FCN1_high|Severe / Condition, Lineage, Cell class and cell subclass | 1.06e-04 | 200 | 104 | 5 | 449623d6786e30d493f68156b3f1ee8caf9265a6 | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.06e-04 | 200 | 104 | 5 | 99eb02f974ddc8d1882f4a5b34d4503d6ec0a5f5 | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.06e-04 | 200 | 104 | 5 | 82126e25bfd8fba78dc1348fa5ad6a576289a139 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 200 | 104 | 5 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col6a1_Fezf2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.48e-04 | 44 | 104 | 3 | 2aa44b57544d5264db5b265ae60f7460c5b2a217 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Nxph1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.92e-04 | 122 | 104 | 4 | dba1c647172a11381efcb178a23808161908daa3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 123 | 104 | 4 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Spon1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.24e-04 | 127 | 104 | 4 | cd69ba386796715e87674f8324d2acaad1d4d094 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.52e-04 | 131 | 104 | 4 | 80630812f8894b9358d36dc2dd03fea7ee870502 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Crh|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.91e-04 | 136 | 104 | 4 | 44f03e4f55fb2c5f8b9397142c89f7194b009cc6 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-04 | 139 | 104 | 4 | 2fb51abb3ce88c21726c026d6365b2582e2e79f6 | |
| Drug | halofuginone | 1.93e-06 | 127 | 104 | 7 | ctd:C010176 | |
| Disease | diverticulitis | 8.46e-06 | 37 | 103 | 4 | EFO_1001460 | |
| Disease | Autosomal dominant epilepsy with auditory features | 3.61e-05 | 3 | 103 | 2 | cv:C1838062 | |
| Disease | X-11261 measurement | 3.61e-05 | 3 | 103 | 2 | EFO_0021221 | |
| Disease | EPILEPSY, FAMILIAL TEMPORAL LOBE, 1 | 3.61e-05 | 3 | 103 | 2 | 600512 | |
| Disease | Epilepsy, Familial Temporal Lobe 1 | 3.61e-05 | 3 | 103 | 2 | C4551957 | |
| Disease | Epilepsy, familial temporal lobe, 1 | 3.61e-05 | 3 | 103 | 2 | cv:C4551957 | |
| Disease | X-24422 measurement | 3.61e-05 | 3 | 103 | 2 | EFO_0800880 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 6.69e-05 | 62 | 103 | 4 | DOID:9074 (is_implicated_in) | |
| Disease | cation-independent mannose-6-phosphate receptor measurement | 7.21e-05 | 4 | 103 | 2 | EFO_0008075 | |
| Disease | polyunsaturated fatty acid measurement | 9.87e-05 | 131 | 103 | 5 | EFO_0010733 | |
| Disease | whole-brain volume | 1.20e-04 | 5 | 103 | 2 | EFO_0005089 | |
| Disease | phospholipids:total lipids ratio | 1.49e-04 | 227 | 103 | 6 | EFO_0020946 | |
| Disease | Hirschsprung Disease | 1.73e-04 | 31 | 103 | 3 | C0019569 | |
| Disease | Complement deficiency disease | 2.09e-04 | 33 | 103 | 3 | C0272242 | |
| Disease | acisoga measurement | 2.51e-04 | 7 | 103 | 2 | EFO_0800068 | |
| Disease | cholesteryl ester measurement | 2.91e-04 | 257 | 103 | 6 | EFO_0010351 | |
| Disease | argininate measurement | 3.33e-04 | 8 | 103 | 2 | EFO_0800055 | |
| Disease | pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) measurement | 3.33e-04 | 8 | 103 | 2 | EFO_0800494 | |
| Disease | Liver carcinoma | 4.10e-04 | 507 | 103 | 8 | C2239176 | |
| Disease | X-11381 measurement | 4.28e-04 | 9 | 103 | 2 | EFO_0021228 | |
| Disease | Secondary Biliary Cholangitis | 4.30e-04 | 42 | 103 | 3 | C0238065 | |
| Disease | Biliary cirrhosis | 4.30e-04 | 42 | 103 | 3 | C0023892 | |
| Disease | Biliary Cirrhosis, Primary, 1 | 4.30e-04 | 42 | 103 | 3 | C4551595 | |
| Disease | autistic disorder (is_implicated_in) | 4.30e-04 | 42 | 103 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | Primary biliary cirrhosis | 5.99e-04 | 47 | 103 | 3 | C0008312 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 6.50e-04 | 197 | 103 | 5 | EFO_0005680 | |
| Disease | non-alcoholic fatty liver disease, cirrhosis of liver | 8.52e-04 | 53 | 103 | 3 | EFO_0001422, EFO_0003095 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.07e-03 | 220 | 103 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | Replication Error Phenotype | 1.23e-03 | 15 | 103 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 1.23e-03 | 15 | 103 | 2 | C0920269 | |
| Disease | Malignant neoplasm of breast | ADAMTS19 NAT2 MICAL1 MCF2L2 CUBN APOBEC3B CXCR5 MSH6 FASN MTR MED12 | 1.33e-03 | 1074 | 103 | 11 | C0006142 |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.38e-03 | 137 | 103 | 4 | EFO_0004611, EFO_0008591 | |
| Disease | uridine diphosphate galactose measurement, uridine diphosphate glucose measurement | 1.59e-03 | 17 | 103 | 2 | EFO_0010543, EFO_0010544 | |
| Disease | Antibody Deficiency Syndrome | 1.59e-03 | 17 | 103 | 2 | C0003257 | |
| Disease | hearing loss | 1.68e-03 | 67 | 103 | 3 | EFO_0004238 | |
| Disease | melanoma | 1.81e-03 | 248 | 103 | 5 | C0025202 | |
| Disease | Phenyllactate (PLA) measurement | 1.99e-03 | 19 | 103 | 2 | EFO_0021662 | |
| Disease | Lupus Erythematosus, Systemic | 1.99e-03 | 71 | 103 | 3 | C0024141 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.06e-03 | 153 | 103 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 2.20e-03 | 20 | 103 | 2 | DOID:3328 (is_marker_for) | |
| Disease | end stage renal disease (implicated_via_orthology) | 2.20e-03 | 20 | 103 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | citrate measurement | 2.69e-03 | 79 | 103 | 3 | EFO_0010114 | |
| Disease | Moderate albuminuria | 2.79e-03 | 80 | 103 | 3 | HP_0012594 | |
| Disease | Immunologic Deficiency Syndromes | 2.91e-03 | 23 | 103 | 2 | C0021051 | |
| Disease | Involutional paraphrenia | 3.44e-03 | 25 | 103 | 2 | C1571983 | |
| Disease | Psychosis, Involutional | 3.44e-03 | 25 | 103 | 2 | C1571984 | |
| Disease | Involutional Depression | 3.44e-03 | 25 | 103 | 2 | C0011574 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CNRRWVYDAIVTESG | 126 | P0DKL9 | |
| FVVYCDIRENRAWTV | 611 | P78357 | |
| GNLRYWLEEAECRDQ | 291 | P55884 | |
| WCYVGVVHRLRQAQR | 236 | P32302 | |
| QCETVYNGEWRELRY | 176 | P07357 | |
| EQESRVHYTVCIWRN | 1461 | P0C0L5 | |
| LCYEVERLDNGTWVL | 216 | Q9UH17 | |
| YRWVCEKRRNATGEV | 296 | P07307 | |
| EIQWDVDTIYHRQGC | 176 | Q6F5E8 | |
| RIVTCGTDRNAYVWT | 66 | O15143 | |
| IRREEAGAYQCEVWN | 191 | Q2WEN9 | |
| QDDCWGYIERVRAAT | 806 | Q96DT5 | |
| LQLWDTAGQERYRCI | 596 | Q9BSW2 | |
| AEQIQYRRGWEEIIS | 256 | Q6MZZ7 | |
| HDWIINRCGTEVRYV | 211 | P53701 | |
| CPVGEQRRNLWTEAY | 531 | Q13117 | |
| RDQWTVYCRVIREKN | 1051 | Q8TE56 | |
| KGDRLVIACQEQTYW | 176 | O94810 | |
| GDQWPVYCRVIREKN | 1166 | Q8TE59 | |
| CVWFYIGQREIESSE | 376 | Q9ULD8 | |
| VRWEYCVRAKRGQTD | 366 | Q68EN5 | |
| RDELVYVSCGELWIN | 996 | M0R2J8 | |
| PIYWSNVRCRGDEEN | 231 | P56730 | |
| WTELNTYVVCRQLGF | 416 | P56730 | |
| EYARYVLRTICQQEW | 1241 | Q86YW9 | |
| RVEIFYRGQWGTVCD | 36 | Q08380 | |
| GVQTCEEVRKLFQWR | 26 | P78333 | |
| WSLEYIQEIAGCRTV | 221 | Q8N371 | |
| AGERTAIYCLTQNEW | 21 | Q6PH85 | |
| RQLDKVSQWCEAGIY | 431 | Q86YR7 | |
| CRKAQVIDLQAEGYW | 176 | Q9UK22 | |
| EWIQYCASRRSQPVD | 1556 | Q9H6A9 | |
| WTVRVCERYHDQQDV | 476 | Q9UGI6 | |
| VARLACADITVNIWY | 186 | Q96RD2 | |
| QWSERVCEEFYRQGE | 336 | Q9NP56 | |
| NVIIWDTNRYTEDGC | 276 | Q5QP82 | |
| EVWLRVDCRNTDQTY | 56 | Q9BYJ0 | |
| QSLLEWCQEVTTGYR | 1041 | Q8N3D4 | |
| LNYDREVVRVWFCNR | 271 | Q14863 | |
| YVLRSICQQEWVGER | 1281 | Q93074 | |
| QEELLRWCQEQTAGY | 511 | Q8TDZ2 | |
| QRISRGYDFCQVLQW | 166 | Q9H223 | |
| VEEVRWRECVGYVNS | 431 | Q495T6 | |
| EKQRNRIGCRTIVYW | 956 | P52701 | |
| RECLNLWGYERVDEI | 441 | Q86U44 | |
| YEQCDAGWLRDQTVR | 521 | P16112 | |
| ENLRVGEVYEACWAL | 331 | P78509 | |
| GYRWDIVAQRASQCL | 316 | Q15646 | |
| ELVGYRVTQIACGRW | 291 | Q9UII4 | |
| NWECIYRITVRTGQL | 1071 | O60494 | |
| IGDVVRIQETCGDWY | 31 | Q92608 | |
| VITFDCRNRGWYIQA | 271 | Q7Z3S7 | |
| FGAVVRWAEAECQRQ | 241 | Q9H0C5 | |
| WARLYANCEDVGVAI | 31 | Q8WWM9 | |
| VASIRVVRGCWVLYE | 1016 | Q8N1P7 | |
| VGTRDWIEGETYQCR | 286 | P01854 | |
| CLTEERGIWYLDQIR | 151 | P11245 | |
| VDCWIDNTRVVYNRS | 96 | P04180 | |
| RRWTVADVRQGCQYE | 801 | Q86VF2 | |
| DQETYRCELIQGWNI | 261 | Q14289 | |
| IRNVARCWTYETAVA | 306 | Q92769 | |
| QEEAVLAAYWRGQCI | 596 | P49327 | |
| GVRLVDNYCEAWRTA | 1331 | P39059 | |
| KCVWEIEVNSGYRIN | 1791 | Q9UGM3 | |
| GQCRRYEVDWNQSAL | 86 | O15245 | |
| CQWFVREAVRTYGRE | 186 | P15086 | |
| GSETVVQRVYQSCRW | 71 | Q96A83 | |
| RRCVVLADGFYEWQR | 116 | Q96FZ2 | |
| EQESRVHYTVCIWRN | 1461 | P0C0L4 | |
| EQLRARSLQGWVCYV | 91 | A9UHW6 | |
| IAVDWESLGYNITRC | 406 | Q15262 | |
| HVNESARYVEVCVWR | 2021 | P0C091 | |
| ARYVEVCVWRRGTDL | 2026 | P0C091 | |
| DQGSYRCIVSEWIAE | 241 | Q9P2B2 | |
| LQDGCEYVFIWRTVE | 1201 | P11717 | |
| VTLCGWIQYRRQNTF | 66 | Q6PI48 | |
| VRCYWVDVTLNSVNL | 296 | Q9BYJ4 | |
| QREVWCVGTNGKRYQ | 546 | Q8WV44 | |
| CEEFWGSQERQRQLY | 211 | P49683 | |
| NVQSEWRLYCVRGEV | 1876 | O95425 | |
| TLWCQGILETQEYRL | 46 | O75019 | |
| WREISVCGNVYTLRD | 256 | Q8N2H9 | |
| RWRNSEIRCYVNGQL | 336 | Q8NFP9 | |
| RRELWAYCGSEQLDV | 1146 | Q99707 | |
| ARVQDLIGLICWQYT | 201 | Q9BPZ7 | |
| NERTYQEVVWAVCGK | 111 | Q9NVC3 | |
| RCAYEVTQANGKWEV | 551 | P61764 | |
| VERNARVIQWLYGCQ | 246 | Q8TAY7 | |
| GIQVSLYCQEWYARR | 486 | O75908 | |
| IGCVVRAHQWLYREI | 71 | P51800 | |
| YGQEIVELRQCWQKR | 231 | Q6ICB4 | |
| IQLTREVDGVWVYNR | 321 | O15105 | |
| QEVQRYETYRWIVGC | 416 | Q8N271 | |
| WVYNELRGQLEECRG | 886 | Q9NR96 | |
| DVGWQVRKTCYRIVE | 1136 | Q9Y5Y9 | |
| ETIVAAPNCTWRNYR | 136 | Q6ZTI6 | |
| VWGIGCEDRAVYFRQ | 346 | Q7Z6L1 | |
| VWGQCQVRIRYLGER | 206 | Q99619 | |
| CIREAVSQVLSGYDW | 71 | P56693 | |
| SACIRWKQDVEGAVY | 16 | Q9HBU9 | |
| EGLRVEDQGWYECRV | 96 | Q9P2J2 | |
| QRGIWSIHVYCVDNI | 241 | Q16222 | |
| CQWLVEYFISSEGRE | 2206 | Q9UPU5 | |
| RRVGVLQGQCWEDFV | 531 | Q7Z403 | |
| EGRWVIYNDQKVCAS | 826 | P45974 | |
| SVERSDAGRYWCQVE | 106 | Q06418 | |
| RQFEEIWERCGGIQY | 1256 | Q9UM54 | |
| IWERCGGIQYLQNAI | 1261 | Q9UM54 |